China Travel Vaccine Market to 2032
Overview
The China Travel Vaccine Market is expected to reach a 399.51 USD Million by 2032 and is projected to grow at a CAGR of 10.33% from 2025 to 2032.
Revenue, 2024 (USD Million)
214.69
Forecast, 2032 (USD Million)
399.51
CAGR, 2024 - 2032
10.33%
Report Coverage
China
China Travel Vaccine Market 2018-2032 USD Million
China Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 214.69 USD Million
- Projected Market Size (2032): 399.51 USD Million
- CAGR (2025-2032): 10.33%
Key Findings of China Travel Vaccine Market
- The China Travel Vaccine Market was valued at 399.51 USD Million in 2024.
- The China Travel Vaccine Market is likely to grow at a CAGR of 10.33% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 176.83 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 16.87% during the forecast period from 2024 to 2032.
China Travel Vaccine Market Scope
China Travel Vaccine Market Segmentation & Scope
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Distribution Channel
- B2C
- B2B
China Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 214.69 USD Million |
| Market Value in 2032 | 399.51 USD Million |
| CAGR (2025-2032) | 10.33% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease,Category,Age Group,Patient Type,Gender,Route of Administration,Type,Composition,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 214.69 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 214.69 USD Million in 2024.
Segments and Scope
-
China Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 43.05 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 16.87 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 103.92 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.73 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 110.27 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.78 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 100.99 USD Million in the year 2024.
- Adult is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.95 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 115.98 USD Million in the year 2024.
- Male is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.54 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 176.83 USD Million in the year 2024.
- Injectable is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.47 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 65.67 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 11.37 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 149.61 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.48 % in forecast period 2025-2032.
-
China Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in China Travel Vaccine Market to 2032 with a revenue of 167.66 USD Million in the year 2024.
- B2B is the Fastest growing segment in China Travel Vaccine Market to 2032 with a Growth rate of 10.49 % in forecast period 2025-2032.
China Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
China Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
China Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Travel Vaccine Market is segmented based on Segmentation Disease,Category,Age Group,Patient Type,Gender,Route of Administration,Type,Composition,Distribution Channel.
China Travel Vaccine Market was valued at USD 214.69(Revenue in USD Million) in 2022.
China Travel Vaccine Market is projected to grow at a CAGR of 10.33% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the China Travel Vaccine Market, holding a largest market share of 176.83 USD Million in 2024
China Travel Vaccine Market Scope
China Travel Vaccine Market Segmentation & Scope
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Distribution Channel
- B2C
- B2B
Frequently Asked Questions
The China Travel Vaccine Market is segmented based on Segmentation Disease,Category,Age Group,Patient Type,Gender,Route of Administration,Type,Composition,Distribution Channel.
China Travel Vaccine Market was valued at USD 214.69(Revenue in USD Million) in 2022.
China Travel Vaccine Market is projected to grow at a CAGR of 10.33% during the forecast period of 2024 to 2032.
The estimated market value of the China Travel Vaccine Market for final year is USD 399.51 (USD Million).
China Travel Vaccine Market Company Profiling
Frequently Asked Questions
The China Travel Vaccine Market is segmented based on Segmentation Disease,Category,Age Group,Patient Type,Gender,Route of Administration,Type,Composition,Distribution Channel.
China Travel Vaccine Market was valued at USD 214.69(Revenue in USD Million) in 2022.
China Travel Vaccine Market is projected to grow at a CAGR of 10.33% during the forecast period of 2024 to 2032.
The estimated market value of the China Travel Vaccine Market for final year is USD 399.51 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.